US5225353A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for immunoselection of cells using avidin and biotin
Assignee: Fred Hutchinson Cancer Center
•
Filing: 1991-10-03
•
Granted: 1993-07-06
•
Expires: 2011-10-03
Abstract
Abstract The selectivity of immunoselection systems employing insolubilized avidin and biotinylated specific antibody is amplified, and nonspecific recovery is improved, by employing an indirect sandwich technique using a biotin-conjugated antispecies immunoglobulin that is directed to one or more nonbiotinylated specific antibodies in conjunction with insolubilized avidin. Specific cell populations can be removed and recovered from bone marrow, providing excellent recovery of bone marrow and preservation of hematopoietic stem cells for transplantation. Mixed populations of T cells or of tumor cells can be conveniently and simultaneously removed with minimal manipulation of the marrow cells. An improved positive immunoselection method provides viable and functional recovered cells, e.g., hematopoietic stem cells or activated killer cells, that can be clinically employed.
Inventors
- 👤 Ronald J. Berenson
- 👤 William I. Bensinger
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-02 05:43
CPC Classifications
A; A61; A61M; A61M1/00; A61M1/36; A61M1/3687; A61M1/3693; A61M1/3696; A61M2202/00; A61M2202/04; A61M2202/0413; A61M2202/0439; A61M2202/10
Claims Analysis
Total Claims: 4
Claim 1
Independent Claim
160 words
A method of immunoselection of target cells comprising the steps of: (a) reacting a suspension containing the cells with a first antibody or fragment thereof having binding specificity for the target cells in order to form antibody/cell first complexes; (b) reacting the suspension with a biotinylated immunoreagent having specificity for said first antibody or fragment thereof, said immunoreagent being selected from the group consisting of antisera, antibodies or fragments thereof, in order to associate said immunoreagent with said first antibody or fragment thereof to form biotinylated immunoreagent/antibody/cell second complexes; (c) reacting the suspension containing the biotinylated second complexes without static incubation with insolubilized avidin contained in a chromatography column or flow-through cartridge in order to associate said avidin with said biotin to form insolubilized avidin/biotinylated immunoreagent/antibody/cell third complexes; (d) separating the third complexes from the suspension; (e) agitating the third complexes to separate the target cells from the third complexes; and (f) recovering viable target cells in substantially enriched form.
Claim 2
Independent Claim
160 words
A method of immunoselection of target cells comprising the steps of: (a) reacting a suspension containing the cells with a first antibody or fragment thereof having binding specificity for the target cells in order to form antibody/cell first complexes; (b) reacting the suspension with a biotinylated immunoreagent having specificity for said first antibody or fragment thereof, said immunoreagent being selected from the group consisting of antisera, antibodies or fragments thereof, in order to associate said immunoreagent with said first antibody or fragment thereof to form biotinylated immunoreagent/antibody/cell second complexes; (c) reacting the suspension containing the biotinylated second complexes without static incubation with insolubilized avidin contained in a chromatography column or flow-through cartridge in order to associate said avidin with said biotin to form insolubilized avidin/biotinylated immunoreagent/antibody/cell third complexes; (d) separating the third complexes from the suspension; (e) agitating the third complexes to separate the target cells from the third complexes; and (f) recovering viable target cells in substantially enriched form.
Claim 3
Dependent Claim
44 words
A kit for removing a specific cell population from a heterogeneous suspension, comprising: insolubilized avidin contained in a chromatography column or flow-through cartridge; first immunoreagent having binding specificity for said specific cell population; and biotinylated second immunoreagent having binding specificity for said first immunoreagent.
Claim 4
Dependent Claim
44 words
A kit for removing a specific cell population from a heterogeneous suspension, comprising: insolubilized avidin contained in a chromatography column or flow-through cartridge; first immunoreagent having binding specificity for said specific cell population; and biotinylated second immunoreagent having binding specificity for said first immunoreagent.
References Cited (Backward Citations)
US4192748A
Cited
US4298685A
Cited
US4228237A
Cited
US4276206A
Cited
US4253996A
Cited
US4468470A
Cited
US4512763A
Cited
US4684609A
Cited
US4496654A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1996-07-05 | 1997-01-04 | 1997-07-06 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2000-07-05 | 2001-01-04 | 2001-07-06 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2004-07-05 | 2005-01-04 | 2005-07-06 | $7700.00 | Window Closed / Lapsed |